Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital (P12-1.009)

To assess the efficacy and safety of cladribine use in patients with active relapsing remitting multiple sclerosis over an extended follow up period in a British cohort.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211552
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital (P12-1.009)

Plaxedes Rabvukwa, Moneeb Nasir, Abhijit Chaudhuri, Laura Azzopardi et al.
2 links
Neurology
Acute Lymphoblastic Leukemia research
article

Extended Follow Up Data on the Efficacy and Safety of Cladribine for Multiple Sclerosis in a Greater London Hospital (P12-1.009)

Plaxedes Rabvukwa, Moneeb Nasir, Abhijit Chaudhuri, Laura Azzopardi, Miriam Mattoscio, Sarah Fuller, Kasun Athukoralage
article en

Abstract

To assess the efficacy and safety of cladribine use in patients with active relapsing remitting multiple sclerosis over an extended follow up period in a British cohort.

NeurologyVol. 104(7_Supplement_1)
Royal London Hospital (GB)
Good health and well-being
Openalex Percentile: Top 90%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.